首页> 外国专利> DERIVATIVES OF ACID 1H-INDOL-3-IL GLIOXILICO REPLACED WITH ARILO, ARILOXI AND ALQULOXI AS INHIBITORS OF THE PLASMINOGEN-1 ACTIVATOR INHIBITOR (PAI-1).

DERIVATIVES OF ACID 1H-INDOL-3-IL GLIOXILICO REPLACED WITH ARILO, ARILOXI AND ALQULOXI AS INHIBITORS OF THE PLASMINOGEN-1 ACTIVATOR INHIBITOR (PAI-1).

机译:取代了以阿里洛,阿里洛西和阿库洛西为纤溶酶原1抑制剂(PAI-1)抑制剂的1H-吲哚-3-IL丙二酸的衍生物。

摘要

Compounds of formula (I): (See formula) in which: R1 is hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, or C1-C3 perfluoroalkyl, in which the alkyl groups and cycloalkyl may be optionally substituted by halogen, -CN, C1-C6 alkoxy, -OH,, -NH2 or -NO2; R2 is hydrogen, C1-C8 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, thienyl, CH2-thienyl, furanyl, CH2furanyl, oxazoyl, CH2-oxazoyl, phenyl, benzyl, or CH2-naphthyl; in which the alkyl group and the rings of the cycloalkyl, thienyl, furanyl, oxazoyl, phenyl, benzyl and naphthyl groups may be optionally substituted by 1 to 3 groups independently selected from halogen, C1-C3 alkyl, C1-C3 perfluoroalkyl, -O-perfluoroC1-C3 alkyl, -S-perfluoroalkyl C1-C3, C1-C3 alkoxy, -OCHF2, -CN, -COOH, -CH2CO2H, -C (O) CH3, -C (O) OR7, -C (O ) NH2, -S (O) 2CH2, -OH, -NH2 or -NO2; R3 is hydrogen, halogen, C1-C6 alkyl, C1-C3 perfluoroalkyl, C1-C6 alkoxy, C3-C6 cycloalkyl, or -CH2-ci C3-C6 cloalkyl; R4 is C3-C8 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, thienyl, CH2-thienyl, furanyl, oxazoyl, phenyl, benzo [b] furan-2-yl, benzo [b] thien-2- yl, benzo [1,3] dioxol-5-yl, or naphthyl; wherein the alkyl group and the rings of the cycloalkyl, thienyl, furanyl, oxazoyl, phenyl, benzofuranyl, benzothienyl and naphthyl groups may be optionally substituted by 1 to 3 groups independently selected from halogen, C1-C3 alkyl, C1-perfluoroalkyl C3, -O-C1-C3 perfluoroalkyl, -S-C1-C3 perfluoroalkyl, C1-C3 alkoxy, -OCHF2, -C (O) CH3, -C (O) OR7, -C (O) NH2, -S ( O) 2CH3, -OH, -NH2 or -NO2; R5 is C1-C8 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, pyridinyl, -CH2-pyridinyl, thienyl, CH2-thienyl, furanyl, CH2-furanyl, oxazoyl, CH2-oxazoyl, phenyl, benzyl, benzo [b] furan-2-yl, benzo [b] thien-2-yl, benzo [1,3] dioxol-5-yl, naphthyl, CH2-naphthyl, 9H-fluoren-1-yl, 9H-fluoren-4 -yl, 9H-fluoren-9-yl, 9-fluorenone-1-yl, 9-fluorenone-2-yl, 9-fluorenone-4-yl, or CH2-9H-fluoren-9-yl; wherein the alkyl group and the rings of the cycloalkyl, pyridinyl, thienyl, furanyl, oxazoyl, phenyl, benzyl, benzofuranyl, benzothienyl, naphthyl, fluorenyl and fluorenone groups may be optionally substituted by 1 to 3 groups independently selected from halogen, C1-C3 alkyl, C3-C6 cycloalkyl, C1-C3 perfluoroalkyl, -O-C1-C3 perfluoroalkyl, -S-perfluoro C1-C3 alkyl, C1C3 alkoxy, -OCHF2, -CN, -COOH, -CH2CO2H, -C (O ) CH3, -C (O) OR7, -C (O) NH2, -S (O) 2CH3, -OH, -NH2, -NO2, or phenoxy, the phenoxy group being optionally substituted by 1 to 3 independently selected groups from halogen, C1-C3 alkyl, or C1-C3 perfluoroalkyl; R6 is hydrogen, C1-C8 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, pyridyl, thienyl, CH2-thienyl, furanyl, CH2-furanyl, oxazoyl, CH2-oxazoyl, phenyl, benzyl, benzo [b] furan-2-yl, benzo [b] thien-2-yl, benzo [1,3] dioxol-5yl, CH2-1-naphthyl, or CH2-2-naphthyl; in which the alkyl group and the rings of the cycloalkyl, thienyl, furanyl, oxazoyl, phenyl, benzyl, benzofuranyl, benzothienyl and naphthyl groups may be optionally substituted by 1 to 3 groups independently selected from halogen, C1-C3 alkyl, C1 perfluoroalkyl -C3, -O-C1C3 perfluoroalkyl, -S-perfluoroalkyl C1-C3, C1-C3 alkoxy, -OCHF2, -CN, -COOH, -CH2CO2H, -C (O) CH3, -C (O) OR7, -C (O) NH2, -S (O) 2CH3, -OH, -NH2 or -NO2; or R5 and R6 taken together may be C3-C6, 3-indan-1-yl, 1, 2, 3, 4-tetrahydronaphthalen-1-yl, chroman-4-yl, 4H-chromen-4-yl, thiochroman -4-yl, 9H-fluoren-9-yl, 9, 10-dihydroantracen-9-yl, 9H-xanten-9-yl, 9-thioxanten-9-yl, 6, 7, 8, 9-tetrahydro-5H-benzocyclohepten -5-yl, or 10, 11-dihydro-5H-dibenzo [a, d] cyclohepten-5-yl, wherein said groups may be optionally substituted by 1 to 3 groups independently selected from halogen, C1-C3 alkyl , perfluoroalkyl C1-C3, -O-perfluoroalkyl C1-C3, -S-perfluoroalkyl C1-C3, alkoxy C1-C3, -OCHF2, -CN, -COOH, -CH2CO2H, -C (O) CH3, -C (O ) OR7, -C (O) NH2, -S (O) 2CH3, -OH, -NH2 or -NO2; and R7 is C1-C6 alkyl, C3-C6 cycloalkyl, -CH2-C3-C6 cycloalkyl, or benzyl.
机译:式(I)的化合物:(参见式)其中:R 1为氢,C 1 -C 6烷基,C 3 -C 6环烷基,-CH 2 -C 3 -C 6环烷基或C 1 -C 3全氟烷基,其中烷基和环烷基可为任选地被卤素,-CN,C 1 -C 6烷氧基,-OH,-NH 2或-NO 2取代; R2为氢,C1-C8烷基,C3-C6环烷基,-CH2-C3-C6环烷基,噻吩基,CH2-噻吩基,呋喃基,CH2呋喃基,恶唑基,CH2-恶唑基,苯基,苄基或CH2-萘基;其中烷基和环烷基的环,噻吩基,呋喃基,恶唑基,苯基,苄基和萘基可任选地被1-3个独立地选自卤素,C1-C3烷基,C1-C3全氟烷基,-O的基团取代-全氟C1-C3烷基,-S-全氟烷基C1-C3,C1-C3烷氧基,-OCHF2,-CN,-COOH,-CH2CO2H,-C(O)CH3,-C(O)OR7,-C(O) NH 2,-S(O)2 CH 2,-OH,-NH 2或-NO 2; R3是氢,卤素,C1-C6烷基,C1-C3全氟烷基,C1-C6烷氧基,C3-C6环烷基或-CH2-C1-C3-C6氯代烷基; R4是C3-C8烷基,C3-C6环烷基,-CH2-C3-C6环烷基,噻吩基,CH2-噻吩基,呋喃基,恶唑基,苯基,苯并[b]呋喃-2-基,苯并[b]噻吩-2-烷基,苯并[1,3]二氧杂-5-基或萘基;其中环烷基的烷基和环,噻吩基,呋喃基,恶唑基,苯基,苯并呋喃基,苯并噻吩基和萘基可任选地被1-3个独立地选自卤素,C1-C3烷基,C1-全氟烷基C3,-的基团取代O-C1-C3全氟烷基,-S-C1-C3全氟烷基,C1-C3烷氧基,-OCHF2,-C(O)CH3,-C(O)OR7,-C(O)NH2,-S(O)2CH3 ,-OH,-NH2或-NO2; R5为C1-C8烷基,C3-C6环烷基,-CH2-C3-C6环烷基,吡啶基,-CH2-吡啶基,噻吩基,CH2-噻吩基,呋喃基,CH2-呋喃基,恶唑基,CH2-恶唑基,苯基,苄基,苯并[b]呋喃-2-基,苯并[b]噻-2-基,苯并[1,3]二氧-5-基,萘基,CH2-萘基,9H-芴-1-基,9H-芴-4 -基,9H-芴-9-基,9-芴酮-1-基,9-芴酮-2-基,9-芴酮-4-基或CH2-9H-芴-9-基;其中环烷基的烷基和环,吡啶基,噻吩基,呋喃基,恶唑基,苯基,苄基,苯并呋喃基,苯并噻吩基,萘基,芴基和芴酮基可任选地被1-3个独立地选自卤素,C1-C3的基团取代烷基,C3-C6环烷基,C1-C3全氟烷基,-O-C1-C3全氟烷基,-S-全氟C1-C3烷基,C1C3烷氧基,-OCHF2,-CN,-COOH,-CH2CO2H,-C(O)CH3 ,-C(O)OR7,-C(O)NH2,-S(O)2CH3,-OH,-NH2,-NO2或苯氧基,苯氧基可被1-3个独立地选自卤素的基团取代, C1-C3烷基,或C1-C3全氟烷基; R6为氢,C1-C8烷基,C3-C6环烷基,-CH2-C3-C6环烷基,吡啶基,噻吩基,CH2-噻吩基,呋喃基,CH2-呋喃基,恶唑基,CH2-恶唑基,苯基,苄基,苯并[b]呋喃-2-基,苯并[b]噻吩-2-基,苯并[1,3]二氧杂-5基,CH2-1-萘基或CH2-2-萘基;其中烷基和环烷基的环,噻吩基,呋喃基,恶唑基,苯基,苄基,苯并呋喃基,苯并噻吩基和萘基可任选地被1-3个独立地选自卤素,C1-C3烷基,C1全氟烷基的基团取代- C3,-O-C1C3全氟烷基,-S-全氟烷基C1-C3,C1-C3烷氧基,-OCHF2,-CN,-COOH,-CH2CO2H,-C(O)CH3,-C(O)OR7,-C( O)NH2,-S(O)2CH3,-OH,-NH2或-NO2;或R5和R6一起可以是C3-C6、3-茚满-1-基,1、2、3、4-四氢萘-1-基,苯并吡喃-4-基,4H-铬-4-基,噻吩基- 4-基,9H-芴-9-基,9、10-二氢蒽基-9-基,9H-黄嘌呤-9-基,9-噻吨基-9-基,6、7、8、9-四氢-5H-苯并环庚基-5-基,或10,11-二氢-5H-二苯并[a,d]环庚基-5-基,其中所述基团可任选地被1-3个独立地选自卤素,C1-C3烷基,全氟烷基的基团取代C1-C3,-O-全氟烷基C1-C3,-S-全氟烷基C1-C3,烷氧基C1-C3,-OCHF2,-CN,-COOH,-CH2CO2H,-C(O)CH3,-C(O)OR7 ,-C(O)NH2,-S(O)2CH3,-OH,-NH2或-NO2; R7为C1-C6烷基,C3-C6环烷基,-CH2-C3-C6环烷基或苄基。

著录项

  • 公开/公告号ES2314289T3

    专利类型

  • 公开/公告日2009-03-16

    原文格式PDF

  • 申请/专利权人 WYETH;

    申请/专利号ES20030812847T

  • 申请日2003-12-09

  • 分类号C07D209/12;C07D209/18;C07D209/22;C07D209/24;C07D401/12;C07D405/06;C07D405/12;C07D417/12;

  • 国家 ES

  • 入库时间 2022-08-21 19:23:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号